Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Daniel Pleguezuelo"'
Autor:
Laura Naranjo, Ljudmila Stojanovich, Aleksandra Djokovic, Laura Andreoli, Angela Tincani, Maria Maślińska, Savino Sciascia, Maria Infantino, Sara Garcinuño, Kinga Kostyra-Grabczak, Mariangela Manfredi, Francesca Regola, Natasa Stanisavljevic, Milomir Milanovic, Jovica Saponjski, Dario Roccatello, Irene Cecchi, Massimo Radin, Maurizio Benucci, Daniel Pleguezuelo, Manuel Serrano, Yehuda Shoenfeld, Antonio Serrano
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
BackgroundAntiphospholipid syndrome (APS) is a multisystemic autoimmune disorder characterized by thrombotic events and/or gestational morbidity in patients with antiphospholipid antibodies (aPL). In a previous single center study, APS-related clinic
Externí odkaz:
https://doaj.org/article/a5d03e23858944a091af89e1ae23fb78
Autor:
Marta López-Nevado, Luis I. González-Granado, Raquel Ruiz-García, Daniel Pleguezuelo, Oscar Cabrera-Marante, Nerea Salmón, Pilar Blanco-Lobo, Nerea Domínguez-Pinilla, Rebeca Rodríguez-Pena, Elena Sebastián, Jaime Cruz-Rojo, Peter Olbrich, Jesús Ruiz-Contreras, Estela Paz-Artal, Olaf Neth, Luis M. Allende
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Primary immune regulatory disorders (PIRD) are associated with autoimmunity, autoinflammation and/or dysregulation of lymphocyte homeostasis. Autoimmune lymphoproliferative syndrome (ALPS) is a PIRD due to an apoptotic defect in Fas-FasL pathway and
Externí odkaz:
https://doaj.org/article/22fefb239cc74ff2812ef5fa1d1e83e7
Autor:
Manuel Serrano, Laura Morán, Jose Angel Martinez-Flores, Esther Mancebo, Daniel Pleguezuelo, Oscar Cabrera-Marante, Juan Delgado, Antonio Serrano
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Background: The presence of anti-Beta 2 glycoprotein antibodies (aB2GP1) of IgA isotype is common in patients with functional impairment of the organs in which B2GP1 is elaborated. Pretransplant IgA aB2GP1 has been associated with increased risk of t
Externí odkaz:
https://doaj.org/article/eab62ab8b6974a28b2c597ae32abe718
Autor:
Carlos Tortosa, Oscar Cabrera-Marante, Manuel Serrano, José A Martínez-Flores, Dolores Pérez, David Lora, Luis Morillas, Estela Paz-Artal, José M Morales, Daniel Pleguezuelo, Antonio Serrano
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0178889 (2017)
The antiphospholipid syndrome (APS) is defined by simultaneous presence of vascular clinical events and antiphospholipid antibodies (aPL). The aPL considered as diagnostics are lupus anticoagulant and antibodies anticardiolipin (aCL) and anti-ß2 gly
Externí odkaz:
https://doaj.org/article/7e89c22cb28e4d09aa6e8f1b214d34bc
Autor:
Manuel, Serrano, José A, Martínez-Flores, Dolores, Pérez, Florencio, García, Oscar, Cabrera-Marante, Daniel, Pleguezuelo, Estela, Paz-Artal, José M, Morales, Esther, González, Antonio, Serrano
Publikováno v:
Circulation. 135(20)
Antiphospholipid syndrome is characterized by recurrent thrombosis and gestational morbidity in patients with antiphospholipid autoantibodies (aPLs). Predictive value of the presence of aPLs is low, and new markers are necessary to identify aPL carri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ccc9b66f65641e9d3e2aedd7fb3bb784
https://pubmed.ncbi.nlm.nih.gov/28249878
https://pubmed.ncbi.nlm.nih.gov/28249878